1. Home
  2. Analysis

Folliculitis and drugs of ingredients of pomalidomide (a real world drug study)


Summary:

Folliculitis is found among people who take drugs with ingredients of pomalidomide, especially for people who are female, 60+ old , have been taking the drugs for 1 - 6 months. This phase IV clinical study is created by eHealthMe based on reports of 94,041 people who have side effects when taking drugs with ingredients of pomalidomide from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Pomalidomide, Pomalyst.

On Aug, 08, 2026

94,041 people reported to have side effects when taking drugs with ingredients of pomalidomide.
Among them, 17 people (0.02%) have Folliculitis

What is Folliculitis?

Folliculitis (infection of hair root) is found to be associated with 688 drugs and 1,070 conditions by eHealthMe. Check the latest studies of Folliculitis.

Number of reports submitted per year:

Could drugs with ingredients of pomalidomide cause Folliculitis?

Time on drugs with ingredients of pomalidomide when people have Folliculitis *:

  • < 1 month: 42.86 %
  • 1 - 6 months: 57.14 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Folliculitis when taking drugs with ingredients of pomalidomide *:

  • female: 60 %
  • male: 40 %

Age of people who have Folliculitis when taking drugs with ingredients of pomalidomide *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 25 %
  • 60+: 75 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Multiple Myeloma (cancer of the plasma cells): 17 people, 100.00%
  2. Tremor (trembling or shaking movements in one or more parts of your body): 2 people, 11.76%
  3. Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 11.76%
  4. Hepatitis B: 2 people, 11.76%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Lenalidomide: 3 people, 17.65%
  2. Carfilzomib: 3 people, 17.65%
  3. Zarxio: 2 people, 11.76%
  4. Ciclosporin: 2 people, 11.76%
  5. Darzalex: 2 people, 11.76%
  6. Decadron: 2 people, 11.76%
  7. Lasix: 2 people, 11.76%
  8. Ninlaro: 2 people, 11.76%
  9. Revlimid: 2 people, 11.76%
  10. Sinemet: 2 people, 11.76%

Other side effects people have besides Folliculitis *:

You may use this to check any potential undetected side effects.

  1. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 17.65%
  2. Oropharyngeal Pain: 3 people, 17.65%
  3. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 3 people, 17.65%
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 17.65%
  5. Itching: 3 people, 17.65%
  6. Rashes (redness): 3 people, 17.65%
  7. Mucosal Inflammation (infection of mucous membrane): 3 people, 17.65%
  8. Headache (pain in head): 2 people, 11.76%
  9. High Blood Pressure: 2 people, 11.76%
  10. Dyspnea (difficult or laboured breathing): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drugs with ingredients of pomalidomide, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on pomalidomide. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.